Predicting patient outcomes after treatment with immune checkpoint blockade: A review of biomarkers derived from diverse data modalities

• Main Authors: Yang Liu (Author), Jennifer Altreuter (Author), Sudheshna Bodapati (Author), Simona Cristea (Author), Cheryl J. Wong (Author), Catherine J. Wu (Author), Franziska Michor (Author)
• Format: Book
• Published: Elsevier, 2024-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Summary: Immune checkpoint blockade (ICB) therapy targeting cytotoxic T-lymphocyte-associated protein 4, programmed death 1, and programmed death ligand 1 has shown durable remission and clinical success across different cancer types. However, patient outcomes vary among disease indications. Studies...